Source: https://www.reuters.com/business/healthcare-pharmaceuticals/definiums-lsd-based-pill-reduces-depression-symptoms-late-stage-trial-2026-06-22/ From the post: >>Definium Therapeutics (DFTX.O), opens new tab said a single dose of its LSD-based experimental pill ​significantly reduced symptoms of major depression in patients in a late-stage ‌trial, sending its shares soaring 55% to a more than four-year high on Monday. The experimental drug helped patients record significantly lower scores on a standard depression scale than those ​on placebo after six weeks, with an 8.1-point difference, meeting the ​trial's main goal, the company said.